Pharmafile Logo

Dedicated

Young girl receives vaccine jab in her arm

Regaining trust in childhood vaccines: can better comms turn the tables on hesitancy and misinformation?

In the wake of Trump questioning MMR vaccines, we review the best practices in vaccine communications and consider how to reverse damage done to public trust in childhood vaccinations.

Say Communications

- PMLiVE

Medscape Education: Pioneering Pathways at ESMO 2025

Medscape Oncology will be pioneering pathways at the 2025 ESMO congress taking place in Berlin, Germany this October.

Medscape Education

- PMLiVE

PMLiVE’s T40 – now open for submissions!

Healthcare agencies can submit their entries free of charge with a deadline of 30 October

- PMLiVE

Roche’s small cell lung cancer therapy approved by FDA

This is the first and only approved combination therapy for extensive-stage small cell lung cancer

- PMLiVE

Indegene acquires BioPharm to advance AI-driven life sciences marketing

The acquisition strengthens Indegene’s AI-enabled commercialisation and AdTech capabilities

- PMLiVE

The impact of US tariffs on healthcare and life sciences multinationals

Ensuring business continuity across clinical, operational and commercial stages

- PMLiVE

Eli Lilly’s Inluriyo approved by FDA for breast cancer

The oral drug can be used to treat advanced or metastatic breast cancer

- PMLiVE

FDA accepts supplemental New Drug Application for Pharming’s paediatric immunodeficiency therapy

If approved, the treatment would be the first for children with APDS under 12 years

- PMLiVE

Porterhouse appoints Jennifer Stewart as Medical Director in US

Jennifer brings over a decade of experience working in biopharma

- PMLiVE

What does it mean to improve outcomes for patients with chronic conditions?

‘What constitutes a positive outcome for patients does not always align with the outcomes of interest to researchers’

- PMLiVE

Game On: Medscape Education Golfs for a Cause

Medscape Education is proud to stand alongside the National Kidney Foundation (NKF) as a sponsor of one of the nation’s most impactful charity events benefiting patients living with kidney disease,...

Medscape Education

Overcoming MS graphic

SAY selects MS healthy lifestyle charity for 2025 pro bono programme

SAY Communications has selected Overcoming MS as the recipient of its annual pro bono programme, offering strategic and creative support to launch the charity’s first public awareness campaign.

Say Communications

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links